Research
Promising findings for the effective treatment of patients with Pulmonary Arterial Hypertension with a high risk of mortality
… at Université Paris-Saclay, head of the Pneumology Department at Bicêtre Hospital (AP-HP), director of the … A previous phase 3 trial (which allowed for a potential market launch to be considered)1 had already produced positive … named ZENITH, offers real hope for high-risk patients despite receiving maximal background therapy for PAH. It has …Published on: